Biora Therapeutics, Inc. (BIOR)

0.7310 +0.0182 (+2.55%) At close: 04:00PM EDT

Biora Therapeutics, Inc.

4330 La Jolla Village Drive
Suite 300
San Diego, CA 92122
United States
833 727 2841
https://www.bioratherapeutics.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 58

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Aditya P. Mohanty M.B.A.	CEO & Director	984.14k	N/A	1967
Mr. Eric d'Esparbes	Chief Financial Officer	748.26k	N/A	1968
Mr. Clarke Neumann J.D.	Senior VP, General Counsel & Secretary	724.62k	N/A	1964
Eric Fox	VP of Finance & Accounting & Treasurer	N/A	N/A	N/A
Mr. George Gianakopoulos	Senior Vice President of Sales	N/A	N/A	1961
Ms. Robyn Hatton	Head of Human Resources	N/A	N/A	N/A
Mr. Kevin Howe Ph.D.	Senior VP of Strategic Operations	N/A	N/A	N/A
Dr. Sharat Singh Ph.D.	Head of Research	N/A	N/A	1959
Dr. Paul Shabram M.B.A.	Head of Technical Operations	N/A	N/A	N/A
Ms. Ariella Kelman M.D.	Chief Medical Officer	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company's offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Corporate Governance

Biora Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.